| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1cd7029ec038fa78d4b371f9bf08e9e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 |
| filingDate |
1998-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1999-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db40c4a28acfd04764762a4e6ac3be92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_096f0da50d64e73c59742cab3f21cd7a |
| publicationDate |
1999-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5998369-A |
| titleOfInvention |
Treatment of osteoporosis |
| abstract |
A substantially pure complex including IGFIIE polypeptide and IGFBP2 polypeptide is described. Methods for treating an osteoporosis patient and targeting a compound to the skeletal extracellular matrix of a patient are also described. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6548482-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7381426-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005053668-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012149634-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9220746-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003203038-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013338033-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6916790-B2 |
| priorityDate |
1997-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |